Edition:
United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

20.45USD
20 Jan 2017
Change (% chg)

$-0.90 (-4.22%)
Prev Close
$21.35
Open
$21.35
Day's High
$21.50
Day's Low
$20.25
Volume
114,448
Avg. Vol
255,102
52-wk High
$28.50
52-wk Low
$10.29

Strobeck, Matthew 

Dr. Matthew W. Strobeck, Ph.D., is Independent Director of Accelerate Diagnostics Inc., since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 124,749
Fiscal Year Total, USD 124,749

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

124,749

Lawrence Mehren

300,000

Steve Reichling

249,381

Pete Bantock

296,203

Mark Miller

124,749

Jack Schuler

124,749
As Of  30 Dec 2015